From:
slider@atashram.com
Last week Mr. Trump said that he has sought help from Prime Minister
Narendra Modi to allow the sale of Hydroxychloroquine tablets ordered by
the US to treat the growing number of coronavirus patients in his country, hours after India banned the export of the anti-malarial drug.
https://www.thehindu.com/news/international/would-be-surprised-if-india-doesnt-allow-export-of-hydroxychloroquine-to-us-trump/article31276161.ece
President Donald Trump has warned India that the US may retaliate if it
did not export anti-malarial drug Hydroxychloroquine despite his personal request, saying he would be surprised in case of a negative outcome as New Delhi has good relations with Washington.
Hydroxychloroquine, an old and inexpensive drug used to treat malaria, is
seen as a viable therapeutic solution by President Trump to coronavirus
that has so far killed more than 10,000 Americans and infected over 3.6
lakh within weeks.
Last week Mr. Trump said he has sought help from Prime Minister Narendra
Modi to allow the sale of Hydroxychloroquine tablets ordered by the US to
treat the growing number of coronavirus patients in his country, hours
after India banned the export of the anti-malarial drug.
“I would be surprised if he would, you know, because India does very well with the United States,” Trump told reporters during a press briefing at
the White House on Monday.
Last month, India imposed a ban on the export on Hydroxychloroquine, on
which Trump is now banking heavily for the treatment of COVID-19 patients.
India has received similar requests from several other countries including
its immediate neighbours Sri Lanka and Nepal. India has said that it is reviewing its export ban order.
Notably, India’s decision to ban the exports of Hydroxychloroquine is
driven by its desire to take stock of the domestic requirements and ensure
that the country has enough in its kitty.
Reiterating that for many years, India has been taking advantage of the US
on trade, Mr. Trump said that he would be surprised if New Delhi was to
stop export of Hydroxychloroquine to the US.
“So, I would be surprised if that were his decision. He’d have to tell me that. I spoke to him Sunday morning, called him, and I said we’d
appreciate your allowing our supply to come out. If he doesn’t allow it to come out, that would be okay, but of course there may be retaliation. Why wouldn’t there be?” Trump said.
His remarks came at a time when both countries are in the grip of the
COVID-19 pandemic.
The Indian Council of Medical Research (ICMR) has recommended the
anti-malarial drug for those involved in the care of suspected or
confirmed cases of the coronavirus and also, for the asymptomatic
household contacts of laboratory confirmed cases.
On Monday, a senior State Department official said that India has been a significant partner of the US in the pharmaceutical sector and it expects similar cooperation to continue between the economies.
India has long been a significant partner of the United States in the pharmaceutical sector, Alice G Wells, the Acting Assistant Secretary of
State for South and Central Asia, told reporters during a press briefing.
The Trump administration has already created a national strategic
stockpile of 29 million doses of the malaria drug, anticipating that its
test results on more than 1,500 COVID-19 patients in New York is yielding positive results.
Global scientists, racing against time to find either a vaccine or a therapeutic cure to the virus, have begun testing Hydroxychloroquine and chloroquine as candidates for potential COVID-19 treatments and the FDA
last week issued an Emergency Use Authorization for the prescription of
the drugs in certain circumstances.
In addition to New York, COVID-19 patients in several States are being
treated with Hydroxychloroquine, including Michigan and Texas.
Based on some initial results, the Trump administration is banking heavily
on using Hydroxychloroquine for the successful treatment of coronavirus.
According to Mr. Trump, the drug is yielding positive results. If
successful, he told reporters that it would be a gift from heaven.
### - the good news there being that the roll-out of hydroxychloroquine
seems to be indeed going ahead in several states in the US including ny
where it's needed most + that by now surely everyone is also demanding
access to it the more people say/suggest that it's actually showing
positive results in the field...
national shortages of this potentially life-saving compound being
something else altogether?
demanding other countries supply them 'with' such compounds seems strange instead of not just making it themselves? like how difficult can this
chemical be to make?? doesn't every country have the basic equipment to
churn it out en-mass if places like india has?
that they 'should' have ALL been making this compound for themselves for
the last 2 or 3 weeks since trump first mentioned it? does it take months
to make or something?? no!
i mean, think of the 'problems' india is personally facing with its
population of 1.4 billion and little in terms of medical support for its
own populace! it's one of the most piss-poor countries on the planet! plus
why in the world wouldn't they treat their own people first before
exporting this completely generic drug to others??
i don't get it! hydroxychloroquine and chloroquine isn't apparently that difficult to manufacture, so why isn't every damn lab in the world
'capable' of making it gearing-up and churning it out en-mass?
governments are literally chucking trillions at the problem from so many different angles just to keep things ticking over otherwise, so why not
chuck a few billions in that direction too and get this stuff MADE instead
of resorting to threatening 'other' countries for 'their' supply which
they are surely going to need just for themselves??
everyone git making it at home ya idiots!
and hurry the fuck up!
geez :)))
--- SoupGate-Win32 v1.05
* Origin: www.darkrealms.ca (1:229/2)